Highlights
NASDAQ: CTMX       Cytomx Thera
Last Price Today's Change   Day's Range   Trading Volume
7.85   -0.01 (0.13%)  7.53 - 7.92  1,413,800

Overview

 
Avg Volume (4 weeks):975,055
4 Weeks Range:6.82 - 9.42
4 Weeks Price Volatility (%):
39.62%
52 Weeks Range:3.595 - 15.44
52 Weeks Price Volatility (%):
35.92%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of unique conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues. The company focuses on developing Probody therapeutics which addresses clinically-validated cancer targets in immuno-oncology that are difficult to drug and lead to concerns about damage to healthy tissues or toxicities.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3337  6104  406  71 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNDL 1.33-0.06 
 XTNT 4.33+2.32 
 SQQQ 14.48+0.22 
 UVXY 9.54-0.06 
 AAPL 121.26-1.33 
 NAK 0.791-0.088 
 SPY 380.36-3.99 
 AMC 8.01-0.18 
 SOS 4.77-1.14 
 VXX 16.03-0.05 

TOP ARTICLES

1. Daily Futures Trading Strategy 26 February 2021 Where Futures Lies
2. Wall Street Breakfast: Stock Markets Obeying The Yield Sign Wall Street Breakfast
3. GameStop Comeback Wall Street Breakfast
4. Equities Higher As Optimism Returned State of The Markets
5. Stocks Rebounded on Feds Support State of The Markets